article thumbnail

Podcast #3: Doing Digital Deals in Life Sciences | Defining & Valuing the Asset

Pharmaceutical Technology

In this series, life sciences industry M&A veteran John Easton will discuss how digital deals differ from traditional life science deals

article thumbnail

Podcast #2: Doing Digital Deals in Life Sciences | Information Governance

Pharmaceutical Technology

In this series, life sciences industry M&A veteran John Easton will discuss how digital deals differ from traditional life science deals

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Digital dilemma in UK’s life sciences job market

Pharmaceutical Technology

In this issue: Digital jobs in UK life sciences, generative AI changes drug discovery, and how robotics is impacting gene therapy manufacturing.

article thumbnail

How life sciences benefits from broader healthcare transformation

Bio Pharma Dive

Digital transformation has much to offer life sciences as well as healthcare — and the synergies between the two can further optimize the power of digital health, clinical trials and patient outcomes.

article thumbnail

Navigating the 2024 Life Science Industry Trends Landscape

Pharma Mirror

As we step into 2024, the global life science industry finds itself at a crossroads, facing plenty of challenges alongside an abundance of exciting opportunities. The pharmaceutical and contract outsourcing space has shifted, with new trends emerging that will shape the future of this rapidly changing industry.

article thumbnail

Forbion raises $1.47bn for two life sciences-focused funds

Pharmaceutical Technology

European life sciences venture capital firm Forbion has raised €1.35bn ($1.47bn) across its two new funds. The Forbion Growth Opportunities Fund II provides support to the expansion of late-stage life sciences companies. The latest fundraising brings the total funds managed by the company to €3bn ($3.28bn).

article thumbnail

TAE Life Sciences Welcomes Dr. Deepak “Dee” Khuntia to Its Board of Directors

Pharma Mirror

As an authority in radiation oncology, Dr. Khuntia joining the board of directors validates BNCT and the work TAE Life Sciences is doing to make it a mainstay of modern cancer care IRVINE, Calif.- FASTRO, to its esteemed Board of Directors.